Aberrant changes of Wnt2/β-catenin signaling pathway induced by sodium nitroprusside in human esophageal squamous cell carcinoma cell lines

Cancer Investigation

Volumn 28, Issue 3, 2010, Pages 230-241

  Wang, Wei ^a   Xue, Lexun ^a,b   Liu, Hongtao ^b   Wang, Pengju ^b   Xu, Peirong ^b   Cai, Yurong ^b  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^b ZHENGZHOU UNIVERSITY   (China)

Author keywords

Apoptosis; Esophageal squamous cell carcinoma; SiRNA; Sodium nitroprusside; Wnt2 catenin

Indexed keywords

BETA CATENIN; CYCLIN D1; MYC PROTEIN; NITROPRUSSIDE SODIUM; PROPIDIUM IODIDE; SMALL INTERFERING RNA; WNT2 PROTEIN;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FLOW CYTOMETRY; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

APOPTOSIS; BETA CATENIN; CARCINOMA, SQUAMOUS CELL; CELL CYCLE; CELL LINE, TUMOR; ESOPHAGEAL NEOPLASMS; HUMANS; NITROPRUSSIDE; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; WNT2 PROTEIN;

EID: 77149149119     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.3109/07357900903095698     Document Type: Article

References (29)

1. Pisani, P.; Parkin, D.M.; Bray, F.; Ferlay, J. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 1999, 83, 18-29.
2. Montesano, R.; Hollstein, M.; Hainant, P. Genetic alterations in esophageal cancer and their relevance to etiology and pathogen-esis: a review. Int J Cancer 1996, 69, 225-235.
3. Eguchi, T.; Nakanishi, Y.; Shimoda, T.; Iwasaki, M.; Igaki, H.; Tachi-mori, Y. Histopathological criteria for additional treatment after endoscopic mucosal resection for esophageal cancer: analysis of 464 surgically resected cases. Mod Pathol 2006, 19, 475-480.
4. Lustig, B.; Behrens, J. The Wnt signaling pathway and its roles in tumor development. J Cancer Res Clin Oncol 2003, 129, 199-221.
5. Conacci-Sorrell, M.; Zhurinsky, J.; Ben-Zéev, A. The cadherin-catenin adhesion system in signaling and cancer. J Clin Invest 2002, 109, 987-991.
6. Willert, K.; Jones, K.A. Wnt signaling: is the party in the nucleus? Genes Dev 2006, 20, 1394-1404.
7. Clements, W.M.; Wang, J.; Sarnaik, A.; Kim, O.J.; MacDonald, J.; Fenoglio-Preiser, C. β-Catenin mutation is a frequent cause of Wnt pathway activation in gastric cancer. Cancer Res 2002, 62, 3503-3506.
8. El-Bahrawy, M.; Poulsom, S.R.; Rowan, A.J.; Tomlinson, I.T.; Alison, M.R. Characterization of the E-cadherin/catenin complex in colorectal carcinoma cell lines. Int J Exp Pathol 2004, 85, 65-74.
9. Dihlmann, S.; Kloor, M.; Fallsehr, C.; Doeberitz, M.V.K. Regulation of Akt1 expression by β-catenin/Tcf/Lef signaling in colorectal cancer cells. Carcinogenesis 2005, 26, 1503-1512.
10. Wang, H.Y.; MacNaughton, W.K. Overexpressed β-catenin blocks nitric oxide-induced apoptosis in colonic cancer cells. Cancer Res 2005, 65, 8604-8607.
11. You, D.; Waeckel, L.; Ebrahimian, T.G.; Lanc-Brude, O.; Foubert, P.; Barateau, V. Increase in vascular permeability and vasodilation are critical for proangiogenic effects of stem cell therapy. Circulation 2006, 114, 328-338.
12. Hou, G.; Xue, L.; Lu, Z.; Fan, T.; Tian, F.; Xue, Y. An activated mTOR/p70S6K signaling pathway in esophageal squamous cell carcinoma cell lines and inhibition of the pathway by ra-pamycin and siRNA against mTOR. Cancer Lett 2007, 253, 236-248.
13. Tian, F.; Zang, W.D.; Hou, W.H.; Liu, H.T.; Xue, L.X. Nuclear factor-κ B signaling pathway constitutively activated in esophageal squa-mous cell carcinoma cell lines and inhibition of growth of cells by small interfering RNA. Acta Biochim Biophys Sin 2006, 38, 318-326.
14. Momota, H.; Nerio, E.; Holland, E.C. Perifosine inhibits multiple signaling pathways in Glial progenitors and cooperates with temo-zolomide to arrest cell proliferation in gliomas in vivo. Cancer Res 2005, 65, 7429-7435.
15. Zhu, H.; Mazor, M.; Kawano, Y.; Walker, M.M.; Leung, H.Y.; Armstrong, K. Analysis of Wnt gene expression in prostate cancer: mutual inhibition by Wnt11 and the androgen receptor. Cancer Res 2004, 64, 7918-7926.
16. Holcombe, R.F.; Marsh, J.L.; Waterman, M.L.; Lin, F.; Milovanovic, T.; Truong, T. Expression of Wnt ligands and Frizzled receptors in colonic mucosa and in colon carcinoma. Mol Pathol 2002, 55, 220-226.
17. Huguet, E.L.; McMahon, J.A.; McMahon, A.P.; Bicknell, R.; Harris, A.L. Differential expression of human Wnt genes 2, 3, 4, and 7B in human breast cell lines and normal and disease states of human breast tissue. Cancer Res 1994, 54, 2615-2621.
18. Uraguchi, M.; Morikawa, M.; Shirakawa, M.; Sanada, K.; Imai, K. Activation of Wnt family expression and signaling in squamous cell carcinomas of the oral cavity. J Dent Res 2004, 83, 327-332.
19. Yasushi, S.; Ichiro, M.; Masanobu, K.; Masao, H.; Fumio, I.; Kazuyoshi, Y. Mutational analysis of the β-catenin gene in gastric carcinomas. Tumor Biol 2001, 22, 123-130.
20. Nakopoulou, L.; Mylona, E.I. Papadaki, E.; Kavantzas, N.; Gi-annopoulou, I.; Markaki, S. Study of phospho-β-catenin subcel-lular distribution in invasive breast carcinomas in relation to their phenotype and the clinical outcome. Mod Pathol 2006, 19, 556-563.
21. Peruzzi, B.; Athauda, G.; Bottaro, D.P. The von Hippel-Lindau tumor suppressor gene product represses oncogenic β-catenin signaling in renal carcinoma cells. Proc Nati Acad Sci USA 2006, 103, 14531-14536.
22. Seidler, H.B.K.; Utsuyama, M.; Nagaoka, S.; Takemura, T.; Kita-gawa, M.; Hirokawa, K. Expression level of Wnt signaling components possibly influences the biological behavior of colorectal cancers in different ages groups. Exp Mol Pathol 2004, 76, 224-233.
23. Okino, K.; Nagai, H.; Hatta, M.; Nagahata, T.; Yoneyama, K.; Ohta, Y. Up-regulation and overproduction of Dvl-1, the human counterpart of the Drosophila dishevelled gene, in cervical squamous cell carcinoma. Oncol Rep 2003, 10, 1219-1223.
24. Gottardi, C.J.; Gumbiner, B.M. Distinct molecular forms of β-catenin are targeted to adhesive or transcriptional complexes. J Cell Biol 2004, 167, 339-349.
25. Gwak, J.; Cho, M.; Gong, S.J.; Won, J.; Kim, D.E.; Kim, E.Y.; Lee, S.S.; Kim, M.; Kim, T.K.; Shin, J.G.; Oh, S. Protein-kinase-C-mediated β-catenin phosphorylation negatively regulates the Wnt/β-catenin pathway. Cell Sci 2006, 119, 4702-4709.
26. Torres, V.A.; Tapia, J.C.; Rodriguez, D.A.; Lladser, A.; Arredondo, C.; Leyton, L.; Quest, A.F.G. E-cadherin is required for caveolin-1-mediated down-regulation of the inhibitor of apoptosis protein survivin via reduced β-catenin-Tcf/Lef-dependent transcription. Mol Cell Biol 2007, 27, 7703-7717.
27. Ishibe, S.; Haydu, J.E.; Togawa, A.; Marlier, A.; Cantley, L.G. Cell confluence hegulates hepatocyte growth factor-stimulated cell morphogenesis in a β-catenin-dependent manner. Mol Cell Biol 2006, 26, 9232-9243.
28. Kim, P.K.; Zamora, R.; Petrosko, P.; Billiar, T.R. The regulatory role of nitric oxide in apoptosis. Int Immunopharmacol 2001, 1, 421-441.
29. Kimura, T.; Nakamura, T.; Murayama, K.; Umehara, H.; Yamano, N.; Watanabe, S. The stabilization of β-catenin leads to impaired primordial germ cell development via aberrant cell cycle progression. Devel Biol 2006, 300, 545-553.